Skip to main content
    I

    Innovate Corp (VATE)

    Official site

    INDUSTRIALS • ENGINEERING & CONSTRUCTION • NYSE

    $4.39
    -0.18 (-3.94%)

    Market Cap: $63.32M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Innovate Corp (VATE) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Innovate (VATE) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Innovate reported EPS of -$0.80. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    29%(6/21)
    Avg Surprise
    -35.36%

    Next Report

    VATE has an expected report date of Mar 24, 2027.

    VATE Earnings Call

    The latest VATE earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 21 quarters below that had an estimate, VATE beat 6, missed 14 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $495.50M, up 42.8% from $347.10M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.80N/AN/AN/AN/AN/AN/AN/ANov 12, 2026$495.50M
    Jun 30, 2026$0.71N/AN/AN/AN/AN/AN/AN/AAug 6, 2026$421.60M
    Mar 31, 2026-$1.29N/AN/AN/AN/AN/AN/AN/AMay 14, 2026$364.80M
    Dec 31, 2025-$0.58N/AN/AN/AN/AN/AN/AN/AMar 26, 2026$382.70M
    Sep 30, 2025-$0.71N/AN/AN/AN/AN/AN/AN/ANov 12, 2025$347.10M
    Jun 30, 2025-$1.67N/AN/AN/AN/A-270.9%N/AN/AAug 5, 2025$242.00M
    Mar 31, 2025-$1.29N/AN/AN/AN/AN/AN/AN/AMay 6, 2025$274.20M
    Dec 31, 2024-$1.13N/AN/AN/AN/AN/AN/AN/AMar 31, 2025$236.60M
    Sep 30, 2024-$1.18N/AN/AN/AN/AN/AN/AN/ANov 6, 2024$242.20M
    Jun 30, 2024$0.98N/AN/AN/AN/AN/AN/AN/AAug 7, 2024$313.10M
    Mar 31, 2024-$0.22N/AN/AN/AN/AN/AN/AN/AMay 7, 2024$315.20M
    Dec 31, 2023-$0.12N/AN/AN/AN/AN/AN/AN/AMar 4, 2024$361.00M
    Sep 30, 2023-$0.09N/AN/AN/AN/AN/AN/AN/ANov 9, 2023$375.30M
    Jun 30, 2023-$0.13N/AN/AN/AN/AN/AN/AN/AAug 9, 2023$368.80M
    Mar 31, 2023-$0.13N/AN/AN/AN/AN/AN/AN/AMay 10, 2023$317.90M
    Dec 31, 2022-$0.09N/AN/AN/AN/AN/AN/AN/AMar 14, 2023$409.30M
    Sep 30, 2022-$0.09N/AN/AN/AN/AN/AN/AN/ANov 2, 2022$423.00M
    Jun 30, 2022-$0.18N/AN/AN/AN/AN/AN/AN/AAug 3, 2022$392.20M
    Mar 31, 2022-$0.18N/AN/AN/AN/AN/AN/AN/AMay 4, 2022$412.80M
    Dec 31, 2021-$0.07-$0.07N/A0.00%In lineN/AN/AN/AMar 9, 2022$394.80M
    Sep 30, 2021-$0.16-$0.10N/A-60.00%MissN/AN/AN/ANov 4, 2021$394.80M
    Jun 30, 2021-$0.27-$0.18N/A-49.56%Miss-105.1%N/AN/AAug 6, 2021$243.80M
    Mar 31, 2021-$0.51-$0.22N/A-131.82%MissN/AN/A1 up, 0 downMay 7, 2021$171.80M
    Dec 31, 2020-$0.03-$0.20N/A+86.60%BeatN/AN/AN/AMar 10, 2021$178.00M
    Sep 30, 2020-$0.96-$3.50N/A+72.57%BeatN/AN/AN/ANov 9, 2020$170.50M
    Jun 30, 2020$5.30-$3.90N/A+235.90%Beat+197.8%N/AN/AAug 10, 2020$181.80M
    Mar 31, 2020-$8.48-$4.90N/A-73.06%MissN/AN/AN/AMay 11, 2020$186.60M
    Dec 31, 2019-$0.66-$0.25N/A-164.00%MissN/AN/AN/AMar 16, 2020N/A
    Sep 30, 2019-$0.85-$2.30N/A+63.04%BeatN/AN/AN/ANov 5, 2019$427.50M
    Jun 30, 2019$1.78-$1.20N/A+248.33%BeatN/AN/AN/AAug 8, 2019$479.20M
    Mar 31, 2019-$0.40-$5.50N/A+92.73%BeatN/AN/AN/AMay 7, 2019$449.00M
    Dec 31, 2018-$0.50-$0.16N/A-212.50%MissN/AN/AN/AMar 12, 2019$524.80M
    Sep 30, 2018-$5.24-$4.20N/A-24.76%MissN/AN/AN/ANov 6, 2018$501.40M
    Jun 30, 2018-$6.90-$4.50N/A-53.33%MissN/AN/AN/AAug 8, 2018$496.80M
    Mar 31, 2018-$8.03-$4.90N/A-63.88%MissN/AN/AN/AMay 10, 2018$453.70M
    Dec 31, 2017-$0.21-$0.11N/A-90.91%MissN/AN/AN/AMar 14, 2018$458.47M
    Sep 30, 2017-$2.12-$0.90N/A-135.56%MissN/AN/AN/ANov 8, 2017$406.41M
    Jun 30, 2017-$3.58-$1.80N/A-98.89%MissN/AN/AN/AAug 9, 2017$378.65M
    Mar 31, 2017-$4.03-$2.10N/A-91.90%MissN/AN/AN/AMay 10, 2017$390.57M
    Dec 31, 2016-$0.47-$0.12N/A-291.67%MissN/AN/AN/AMar 8, 2017$453.98M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.26, after -$1.56 the year before. It was -$3.27 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.26N/A
    Dec 31, 2024-$1.56N/A
    Dec 31, 2023-$0.47N/A
    Dec 31, 2022-$0.54N/A
    Dec 31, 2021-$1.01N/A
    Dec 31, 2020-$4.17N/A
    Dec 31, 2019-$0.13N/A
    Dec 31, 2018-$20.67N/A
    Dec 31, 2017-$9.94N/A
    Dec 31, 2016-$3.27N/A

    Earnings Calls

    The 7 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 2,700 words across 4 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20262,7394
    2026Q1Mar 31, 20262,3004
    2025Q3Sep 30, 20252,3844
    2025Q2Jun 30, 20252,4174
    2025Q1Mar 31, 20252,5474
    2024Q3Sep 30, 20242,6555
    2024Q2Jun 30, 20243,2485

    2026Q3 Earnings Call

    Opening remarks

    Jenna Kozlowski Investor Relations Good afternoon. Thank you for being with us to review INNOVATE's third quarter 2026 earnings results. We are joined today by Paul Voigt, INNOVATE's Interim CEO, and Mike Sena, INNOVATE's CFO. We have posted our earnings release and our slide presentation on our website at innovatecorp.com. We will begin our call with prepared remarks to be followed by a Q&A session. This call is also being simulcast and will be archived on our website. During this call, management may make certain statements and assumptions which are not historical facts, will be forward-looking, and are being made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risks, assumptions, and uncertainties, and are subject to certain assumptions and risk factors that could cause INNOVATE's actual results to differ materially from these forward-looking statements. The risk factors that could cause these differences are more fully discussed in the cautionary statement that is included in our earnings release and the slide presentation, and further detailed in our 10-Q, 10-K, and other filings with the SEC. In addition, the forward-looking statements, including those made during the conference call, are only made as of the date of this call and as stated in our SEC reports. INNOVATE disclaims any intent or obligation to update or revise these forward-looking statements, except as expressly required by law. Management will also refer to certain non-GAAP financial measures, such as adjusted EBITDA. We believe that these measures provide useful supplemental data that, while not a substitute for GAAP measures, allow for greater transparency in the review of our financial and operational performance. Reconciliation of these measures to the most comparable GAAP measures is included in our earnings release and presentation. At this point, it is my pleasure to turn things over to Paul Voigt.

    Paul Voigt Interim CEO Good afternoon. We are pleased to report our third quarter 2026 financial results and provide an update on our operating segments. For the third quarter, INNOVATE delivered consolidated revenues of $495.5 million and adjusted EBITDA of $40.5 million. INNOVATE delivered a strong third quarter, highlighted by exceptional performance at DBM Global and continued progress across our portfolio. DBMG delivered another significant quarter ahead of the completion of its sale in October, while MediBeacon continued to advance commercial adoption and key reimbursement initiatives. At Spectrum, we completed the sale of a controlling interest in broadcasting while retaining meaningful participation in the business, and R2 continued to generate healthy underlying demand. Before we turn to operating highlights, I would like to provide an update on the significant progress we have made simplifying INNOVATE's portfolio and unlocking value for shareholders.

    Frequently Asked Questions About VATE

    When is Innovate's next earnings date?

    Innovate's next earnings report is expected for Mar 24, 2027.

    How often does VATE beat earnings estimates?

    Innovate beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of +10.08%.